Showing 4211-4220 of 4945 results for "".
- New Personalized Medicine Approach May Help Treat Even the Most Challenging Woundshttps://practicaldermatology.com/news/new-personalized-medicine-approach-to-wound-healing-may-help-treat-even-the-most-challenging-wounds/2458172/An experimental treatment that allows the reprogramming of blood cells to promote the healing process of cutaneous wound may be beneficial in healing challenging wounds. “We discovered a way to modify specific white blood cells – the macrophages – and make them capable o
- Sensus Healthcare Wins Technology Award from Greater Miami Chamber of Commercehttps://practicaldermatology.com/news/sensus-healthcare-wins-technology-award-from-greater-miami-chamber-of-commerce/2458174/Sensus Healthcare, Inc. was awarded the 2017 Technology Leader of the Year for the Disruptive Technology by The Greater Miami Chamber of Commerce. Sensus provides a non-invasive, cost-effective treatment for NMSC and keloids using the company’s proprietary,
- Unilever Ventures Invests in Nutrafolhttps://practicaldermatology.com/news/unilever-ventures-invests-in-nutrafol/2458189/Unilever Ventures, the venture-capital and private-equity arm of consumer packaged goods conglomerate, has emerged as lead investor at the conclusion of series A financing round for Nutrafol®. Investment platform CircleUp made an initial introduction to
- FDA Accepts Aclaris Therapeutics' NDA for Topical Treatment of Seborrheic Keratosishttps://practicaldermatology.com/news/fda-accepts-aclaris-therapeutics-nda-for-topical-treatment-of-seborrheic-keratosis/2458188/The FDA has accepted Aclaris Therapeutics' New Drug Application (NDA) for A-101 40% topical solution, an investigational drug for the potential treatment of seborrheic keratosis (SK). The NDA acceptance by the FDA in its 74-day letter indicates that the application is sufficiently complete to
- BioPharmX Reports Positive Topline Results of BPX-01 Topical Minocycline for Acnehttps://practicaldermatology.com/news/biopharmx-reports-positive-topline-results-of-bpx-01-topical-minocycline-for-acne/2458198/BioPharmX Corporation’s topical minocycline for acne, BPX-01, achieved its primary endpoint in a phase 2b clinical trial. There were statistically significant reductions in non-nodular inflammatory acne lesions when compared to vehicle in both the 1 percent and 2 percent doses of BP
- Nutrition for Healing Introduces MEND Cosmetic to Support Improved Healing & Recovery From Cosmetic Surgeryhttps://practicaldermatology.com/news/nutrition-for-healing-introduces-mend-cosmetic-to-support-improved-healing-recovery-from-cosmetic-surgery/2458201/Nutrition For Healing LLC launched its new MEND Cosmetic, which is now available through cosmetic surgeons worldwide. The all natural formula, a blend of clinically researched, proven ingredients designed specifically to support healing from cosmetic surgery,
- Foamix Announces Additional Phase 3 Trial for FMX101 in Moderate to Severe Acnehttps://practicaldermatology.com/news/foamix-announces-additional-phase-3-trial-for-fmx101-in-moderate-to-severe-acne/2458203/Foamix Pharmaceuticals is launching an additional Phase 3 trial for FMX101 in moderate to severe acne, a topical minocycline treatment. If the results are positive, this new Phase 3 trial is expected to form the basis for a New Drug Application (NDA) which the company plans to submit in t
- Is Widespread Vitamin D Deficiency Due to Chronic Disease, Sunscreen Use? New Study Says Yeshttps://practicaldermatology.com/news/is-widespread-vitamin-d-deficiency-due-to-chronic-disease-sunscreen-use-new-study-says-yes/2458205/Nearly 1 billion people worldwide may have deficient or insufficient levels of vitamin D due to chronic disease and inadequate sun exposure related to sunscreen use, according to a study in the Journal of the American Osteopathic Association.
- Coolibar Gets Gross To Prevent Skin Cancerhttps://practicaldermatology.com/news/coolibar-gets-gross-to-prevent-skin-cancer/2458206/Sun protective clothing and accessory maker Coolibar’s new skin cancer prevention and awareness campaign may make you sick, and that’s kind of the point. Called "Let's Get Gross," the new campaign will feature stories f
- Kourtney Kardashian's Fave Skincare Brand Rolls Out New Body Oil Collectionhttps://practicaldermatology.com/news/kourtney-kardashians-fave-skincare-brand-rolls-out-new-body-oil-collection/2458212/Manuka Doctor is launching their newest body oil collection --The Manuka Doctor 24K Gold & Manuka Honey. The brand, which boasts Kourtney Kardashian as their global ambassador, is rolling out the new collection in late April 2017. The bo